Sterile Injectable CDMO in India: Manufacturing, Fill-Finish, Technology & Regulatory Guide 2026

Sterile Injectable Manufacturing Requirements in India: Schedule M, Cleanrooms and Sterility Assurance

Sterile injectable manufacturing in India operates under the Revised Schedule M framework, which aligns domestic GMP standards more closely with WHO, US FDA, and EMA expectations.

For pharmaceutical companies selecting a sterile injectable CDMO, understanding these requirements is essential.

A CDMO’s ability to meet Schedule M cleanroom classifications, environmental controls, monitoring systems, and sterility assurance practices directly determines its suitability for aseptic products.

The following sections outline the key regulatory and operational elements that shape CDMO selection.

Schedule M Requirements

Schedule M sets out specific GMP requirements for sterile products and parenteral preparations. It mandates systematic risk assessments at every stage of production, including cleanroom operations, to identify potential hazards and implement control measures. Quality Risk Management (QRM) forms a central principle.

Key expectations under the revised framework include:

• Real-time monitoring of purified and water systems
• Properly designed and maintained HVAC and AHU systems that control temperature, humidity, pressure differentials, and particulate levels
• Continuous environmental and microbiological surveillance to verify cleanroom classifications
• Encouragement of Electronic Batch Records for traceability and auditability
• Adequate personnel training in GMP and cleanroom protocols
• Comprehensive gap analysis followed by timely CAPA implementation

Different implementation timelines apply according to the scale of the manufacturing unit, with MSMEs receiving staggered deadlines. These provisions aim to raise sterility assurance and improve global market access for Indian manufacturers.

When evaluating a CDMO, buyers should confirm that the facility has completed the required gap analysis, maintains validated systems, and operates under a documented Contamination Control Strategy.

Grade A/B/C/D Areas

Schedule M distinguishes four grades of clean areas for sterile manufacturing. Each grade defines operational limits for airborne particles and determines the activities that may take place inside it.

• Grade A is the local zone for high-risk operations such as filling, making aseptic connections, stopper bowls and open ampoules or vials. It is normally achieved with unidirectional airflow that delivers a homogeneous air speed of 0.36–0.54 m/s. Particle limits correspond to ISO 5 both at rest and in operation (maximum 3,520 particles ≥0.5 µm per cubic meter).
• Grade B provides the background environment for the Grade A zone during aseptic preparation and filling. At rest it meets ISO 5 limits; in operation it corresponds to ISO 7 (up to 352,000 particles ≥0.5 µm per cubic meter). Sinks and drains are not permitted. Continuous particle monitoring with alarms is required.
• Grade C supports less critical stages, such as preparation of solutions that will be filtered or filling of products intended for terminal sterilization. Particle limits equate to ISO 7 at rest and ISO 8 in operation.
• Grade D is used for the least critical activities, including cleaning of equipment and handling of components after washing. At rest, it corresponds to ISO 8; in-operation limits depend on the specific process.

Airlocks (personnel and material) separate these grades and prevent cross-contamination. Cascade, bubble or sink configurations may be used according to process needs. CDMOs must demonstrate that each grade is correctly classified, monitored, and maintained under both “at rest” and “in operation” conditions.

Also Read: Indian CDMO 2.0 Guide: Risk-Sharing and Hybrid Models